| Metric | Value (₹ Cr) | vs Q1 FY27 |
|---|---|---|
| Revenue | 42.67 | 25.1% |
| Total Income | 43.79 | 23.7% |
| Expenditure | 33.19 | 28.3% |
| PBT | 10.60 | 11.2% |
| Net Profit | 8.55 | 14.1% |
| OPM | 28.02% | |
| NPM | 19.52% | 1.63pp |
| EPS | 1.91 | 11.2% |
Sequential Strength, But the ₹250 Crore Question Looms
Q2 delivered strong 25% sequential revenue growth and margins hit the target band. But management's FY28 forecast—₹250 crore, or 62% growth—leans heavily on new segments still in testing. The street's 35% drawdown from highs suggests it's pricing in that execution risk.
₹42.7 Cr
+25.1% QoQ; annualized ₹171 Cr
₹154 Cr
annualized from ₹76.8 Cr actual
₹250 Cr
requires 62% growth; new segments unproven
28.0%
H1 at 29.3%; target 30% ±2pp
The earnings print is solid: Q2 revenue hit ₹42.7 crore (+25.1% QoQ), PAT rose to ₹8.5 crore (+14.1% QoQ), and EBITDA margin sits at 28%, well within the management's 30% ±2 percentage point guidance band. The delivered results validate what management said on the call. But beneath that operational strength sits an unresolved question: can the company actually grow from a current run-rate of ₹154 crore (H1 annualized) to ₹250 crore in FY28—a 62% leap—when the incremental revenue depends on industrial and defence shafts that are still in 6–12 month testing cycles?
What the numbers say
Q2 shows sequential momentum intact. Revenue ₹42.7 crore vs. Q1's ₹34.14 crore = 25.1% growth. PAT ₹8.5 crore vs. Q1's ₹7.46 crore = 14.1% growth. EBITDA margin stands at 28%, with H1 average at 29.3%—both comfortably in the targeted 28–32% band. The order book is ₹68–70 crore, representing roughly 1.5 times the FY27 full-year guidance (>₹180 crore), and 78% export-weighted, supporting near-term visibility. But the H1 run-rate of ₹154 crore annualized leaves a ₹96 crore gap to the FY28 target. That gap is the full ₹250 crore story—and it rests on two unproven pieces.
Q2 revenue grew 25% sequentially
₹42.67 Cr vs ₹34.14 Cr Q1 = 25.1% QoQ
Supported
PAT increased 14% sequentially
₹8.5 Cr vs ₹7.46 Cr Q1 = 14.1% QoQ
Supported
EBITDA margin ~30% going forward
Q2 at 28%, H1 at 29.3%; both in 30% ±2pp band
Supported
Revenue targeting ~₹250 Cr FY28
Annualized H1 run-rate is ₹154 Cr; target requires 62% growth
Overstated (dependent on unproven new segments)
What changed on this call
Capacity roadmap crystallized: Pithampur 900k → 1.8M units by Q4 FY27; Dewas 3k → 5.5k tonnes by Q1 FY28
Order book disclosed: ₹68–70 crore (78% export, 22% domestic)
New-segment timelines specific: Industrial shafts ramp FY28; defence still in 6–12 month testing
Universal joints in-house by Nov 2026 targeted for margin uplift
The bull-bear ledger
Strong sequential growth (25% revenue, 14% PAT) and margin expansion (22% FY26 → 28% Q2)
Repeat customer base solid at 87.4%; 13 new customers added Q2 (organic expansion)
Order book at 1.5× FY27 guidance, supporting near-term revenue visibility
Capacity expansion on schedule (equipment ₹50 Cr purchased, ₹30 Cr more on order)
FY28 target (₹250 Cr = 62% growth) contingent on industrial & defence shafts exiting testing phase
Export concentration at 82.4% (H1 FY27), US exposure 59.6% of exports; geopolitical/macro risk
Working capital cycle at 248–249 days; improvement to 200–230 days not yet realized
Global competitors (Dana, Spyker, Cummins, Neapco) entrenched; pricing power unproven at scale
Risks, ranked by how much they should concern a holder
New-segment revenue timing
HighIndustrial and defence shafts in 6–12 month testing. Delays would derail ₹250 Cr FY28 target and require aggressive catch-up.
Export concentration & US exposure
Medium82.4% of H1 revenue from exports, 59.6% of exports to US. Tariffs, trade friction, or US macro slowdown pose material revenue risk.
Working capital intensity at scale
MediumCurrent cycle 248–249 days. Growth to ₹250 Cr FY28 requires incremental WC and capex; improvement to 200–230 days not yet achieved.
Capacity ramp execution
MediumPithampur and Dewas expansions (Q4 FY27, Q1 FY28) critical to FY28 target. Installation delays would crimp near-term upside.
Competitive intensity
MediumGlobal leaders (Dana, Spyker, Cummins, Neapco) entrenched. Pricing power and customer stickiness unproven at Adroit's anticipated scale.
How the street is reading it
The stock announced results on 12 October 2026 at ₹193.8 (pre-result close) and fell 4.82% on day 1, fading to −1.16% by day 3. The initial sell-off was sharp but did not hold—a sign the market absorbed the numbers without panic. However, the stock is now trading at ₹167.65, down 35.47% from its all-time high of ₹259.8 and only 11.03% above its 52-week low of ₹151. Trading below its 20-day SMA of ₹187.67 with RSI at 28.9 (oversold), and volume decreasing, the stock is showing exhaustion sellers rather than conviction.
Bulk deal activity over the past six months shows mixed institutional flows—PRIJAL TRADEFIN and SETU SECURITIES alternating buys and sells in similar magnitudes—with no evidence of sustained insider or promoter selling near the highs. This suggests the drawdown reflects fundamental skepticism about the FY28 growth narrative rather than insider dumping. The 35% drawdown from ATH, coupled with oversold RSI and decreasing volume, could signal a capitulation low—but only if the next quarter confirms capacity expansion and new-segment momentum are real.
1 · H2 FY27 run-rate & FY27 full-year result
Management targets >₹180 Cr FY27 full-year. H1 ₹76.8 Cr means H2 must deliver ₹103.2+ Cr (34% sequential growth). If H2 merely repeats H1 pace or decelerates, the >₹180 Cr target is missed and FY28 credibility sinks.
2 · Capacity commissioning timeline (Q4 FY27, Q1 FY28)
Pithampur doubling (900k → 1.8M units) and Dewas ramp (3k → 5.5k tonnes) are the foundation of 62% FY28 growth. Any delay signals ₹250 Cr is at risk.
3 · Industrial & defence revenue traction
By Q3/Q4 FY27, look for evidence that shafts are exiting testing phase and generating material revenue. Silence or delays here would confirm the FY28 target is overstated.
Adroit delivered a solid Q2: sequential growth is real, margins are in band, and the order book supports near-term revenue. The operational story is not broken. But the ₹250 crore FY28 target—central to the bull case—is contingent, not certain. New segments in testing, export concentration, and working capital intensity are all real headwinds. The street's 35% drawdown from highs prices in real execution risk, and rightly so.
The number to track from here is simple: H2 FY27 run-rate. If sequential momentum holds (or accelerates toward that >₹180 Cr full-year target), the near-term thesis is intact. If H2 disappoints—staying flat or declining—then the FY28 story is much harder to believe, and the stock has further to fall. The capacity ramps (Q4, Q1) and early industrial/defence revenue pulls are the next two credibility tests. For now, the call is steady execution, not a step-change; show, don't tell.
Strong QoQ growth, margin at target; capacity expansion on track
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 7/10
Grade B
First earnings call post-IPO; Q2 delivery aligns with stated QoQ/H1 growth rates. No prior guidance to validate.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong sequential growth (25% revenue, 14% PAT) with margin expansion to 28% EBITDA validates operational execution. Specific FY28 target (Rs. 250 Cr) and capacity expansion roadmap (Pithampur 1.8M units by Q4, Dewas 5,500 tonnes by Q1 FY28) provide visibility. Key risk: industrial/defence segments in testing phase (6-12 months), unproven revenue contribution.
₹42.7 Cr
Revenue · +null% YoY₹8.5 Cr
Reported PAT · +51% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 revenue grew 25% sequentially
METConfirmed: Q2 revenue ₹42.67 Cr vs ₹34.14 Cr Q1 = 25.1% QoQ
PAT increased 14% sequentially
METConfirmed: Q2 PAT ₹8.5 Cr vs ₹7.46 Cr Q1 = 14.1% QoQ
EBITDA margin ~30% going forward
METQ2 EBITDA margin 28.0%, H1 margin 29.3%; in target range but not above it
Expecting revenue ~Rs. 250 crore FY28
OVERSTATEDCurrent run-rate ₹76.8 Cr H1 → ₹154 Cr annualized FY27; Rs. 250 Cr FY28 = 62% growth required
Earnings quality
What changed since the last call
Capacity roadmap crystallized
NewPithampur: 900k→1.8M units (Q4 FY27); Dewas: 3k→5.5k tonnes (Q1 FY28). First concrete capex update post-IPO.
Order book disclosed
New₹68-70 Cr order book, 78% export / 22% domestic. Provides visibility on near-term revenue.
New segment timelines
NewIndustrial shafts scale in FY28; defence in testing (6-12 months). Earlier aspirational, now specific.
The Q&A
Analysts pressed on industrial/defence revenue realization (6-12 month test cycles), working capital at scale (248-249 days), and capacity utilization (93-94% forge, 81% Pithampur). MD held firm on execution roadmap and no-fundraising need; transparent on competitive landscape but guarded on new-segment timelines.
Industrial/defence scaling — Naman Desai, Sunrise India Growth Fund
AnsweredTesting period 6-12 months; several shafts in testing now. Expect revenue ~Rs. 250 Cr FY28 across all segments.
Defence shaft specs — Prabir Adhikary, Fortune Asset Managers
AnsweredUp to 3m length, up to 47,000 newton-metres torque. Competitors: Dana, Spyker, Cummins, Neapco. Differentiation through testing and validation.
Working capital at scale — Vignesh Iyer, Sequent Investments
AnsweredCurrent cycle 248-249 days; expect improvement to 200-230 days. Can manage growth without additional funds.
Revenue/margin mix — Prithvi Bhatt, Abakkus Investment Managers
Answered64-65% components, 35-36% finished shafts. Finished shafts 5-10% higher margin. Targeting universal joints by Nov 2026 to lift margins further.
Order book composition — Prithvi Bhatt, Abakkus Investment Managers
Answered₹68-70 Cr order book; 78% export, 22% domestic. Strong geographic diversification.
International expansion — Sahil Shinde, Vaya Research
AnsweredUS and South America strongest. US subsidiary started operations; Memphis distribution centre. Targeting US, Canada, Colombia, Ecuador, Peru, Chile, Venezuela. European expansion in FY28.
Capacity utilization and FY31 vision — Prakshal Jain, Axiom Research
AnsweredForge 93-94%, Pithampur 81%. >Rs. 180 Cr FY27 target, Rs. 475-500 Cr FY31 mid-term vision with expanded platforms.
Guidance
FY27: >Rs. 180 Cr full-year
MediumImplies H2 needs ~₹103 Cr. H1 ₹77 Cr annualizes to ₹154 Cr; so >₹180 Cr needs 17% H2 acceleration.
FY28: ~Rs. 250 Cr
Medium62% growth from ₹154 Cr annualized FY27. Contingent on capacity ramp (Q4 FY27, Q1 FY28) and new-segment revenue (industrial, defence).
FY31 mid-term: Rs. 475-500 Cr
LowCAGR ~32-35% over 4 years. Assumes capacity fully utilized and new segments scaled. Aspirational; no detailed roadmap provided.
EBITDA margin: ~30% ±2pp going forward
HighSupported by disciplined procurement, manufacturing efficiency, pricing. Q2 at 28%, H1 at 29.3%; confidence in 30% level.
Finished shaft margins 5-10% higher than components
HighValue addition through assembly/balancing. Universal joints by Nov 2026 to add further uplift.
Pithampur: 900k → 1.8M units (by Q4 FY27)
HighEquipment ordered; machinery 50M Rs. purchased, 30M Rs. more on order. Phased ramp expected most operational in Q4.
Dewas: 3k → 5.5k tonnes (by Q1 FY28)
HighEquipment orders released; full ramp-up post-commissioning in Q1 FY28.
Universal joints in-house by Nov 2026
MediumCurrently procured; intent to manufacture in-house by year-end for margin improvement.
Risks the call surfaced
New-segment revenue timing
HighIndustrial and defence shafts in testing phase (6-12 months). Revenue ramp-up critical to achieve Rs. 250 Cr FY28 target. Delays would require aggressive catch-up.
Export concentration
MediumH1 FY27: 82.4% of revenue from exports, with US 59.6% of export sales. Tariffs, trade friction, or US macro slowdown pose material revenue risk.
Working capital intensity
MediumCurrent cycle 248-249 days; expected to improve to 200-230 days with India OEM mix. Inventory held in Canada/US for local shipment. Growth to Rs. 250 Cr FY28 would require significant incremental WC and capex.
Capacity ramp execution
MediumPithampur machining (900k→1.8M units by Q4 FY27) and Dewas forging (3k→5.5k tonnes by Q1 FY28) expansions critical to FY28 target. Installation, commissioning, ramp-up delays would crimp revenue.
Competitive intensity
MediumGlobal competitors (Dana, Spyker, Cummins, Neapco) in propeller shaft market. New-segment entry (industrial, defence) faces entrenched players. Pricing power and customer stickiness unproven at scale.
Management
Score 7/10. Clear and transparent on product specs, capacity roadmap, and competitive landscape. MD provided specific technical details (shaft lengths, torque specs) and names competitors. Withheld minimal detail on new-segment timelines (understandable given testing phases). IPO capital deployment on schedule (Rs. 50 Cr purchased, Rs. 30 Cr on order). Q2 delivery aligns with stated sequential and YoY growth. No prior guidance misses to judge, but track record of margin expansion (22% FY26 → 28-29% H1 FY27) supports credibility.
1 · Q4 FY27
Pithampur machining capacity doubles to 1.8M units; ramp validation
2 · Q1 FY28
Dewas forging capacity expansion (3k to 5.5k tonnes) operational
3 · Nov 2026
Universal joints in-house manufacturing completed; margin uplift target
Key risk: industrial/defence segments in testing phase (6-12 months), unproven revenue contribution.